EUCTR2014-003339-21-ES进行中(未招募)不适用
Open, randomized, with two parallel treatment groups combined therapywith bleomycin and with bleomycin electrochemotherapy (EQ) in patientswith plantar warts large clinical trial virus.Diagnosis and monitoring with confocal microscopy. - VEPLA
Institut d'Investigació Sanitària Pere Virgili (IISPV)0 个研究点开始时间: 2015年3月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •a) Age ? 18 years.
- •b) Signed informed consent.
- •c) Histological confirmation of wart / s plantar / is viral / s.
- •d) Patients belonging to the area of specialized care of Dermatology Department of Pius Hospital de Valls.
- •e) Failure of previous conventional treatments (cryosurgery, surgery, electrocautery, topical immunomodulators).
- •f) Minimum size of the plantar wart: 0.5 cm.
- •g) Presence of single lesion or multiple lesions equal to or greater than 3 cm distance between them in the foot (both included).
- •h) Ability of patients to follow instructions
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 84
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 84
排除标准
- •a) Background Raynauld phenomenon, peripheral vascular disease or collagen disease known.
- •b) known heart disease
- •c) Previous use of bleomycin
- •d) No informed consent signed or removal thereof
- •e) Pregnancy or lactation
研究者
相似试验
已完成
不适用
Comparative Bioavailability study of two different formulations of Clozapine in Schizophrenic PatientsCTRI/2016/09/007290JSC Valenta Pharm18
已完成
不适用
Bioequivalence study of Rosuvastatin 20mg of Sobhan Darou Pharm Co.IRCT20190706044111N15Sobhan Darou Pharm. Co.24
招募中
不适用
Bioequivalence study of Rosuvastatin 40mg tablet of Cosar Pharm Co., IRAHyperlipidemia.Hyperlipidemia, unspecifiedE78.5IRCT20190706044111N19Cosar Pharm. Co.24
已完成
不适用
Bioequivalence study of Rosuvastatin 20mg tablet of Tolidarou Pharm Co., IRAIRCT20190706044111N16Tolidaru Pharmaceutical Company24
尚未招募
Unknown
Bioequivalence study of Famotidine 40mg tablet of Amin Pharm Co., IRAstomach ulcers.histamine H2-receptor blockersT47. 0X3IRCT20190706044111N36Amin Pharm. Co.24
